Comparison of Clinical Outcomes, Risks, and Costs for 20,910 Donor In Vitro Fertilization and 16,850 Donor Artificial Insemination Treatment Cycles: A Retrospective Analysis in China.

Xue-Feng LuoHui-Lan WuXi-Ren JiYu-Lin TangWen-Jun ZhouZeng-Hui HuangQian LiuLi-Qing FanChuan HuangWen-Bing Zhu

Published in: Journal of clinical medicine (2023)

AI-D is more cost-effective and poses a lower risk for infertility couples than IVF-D, and patients should undergo three AI-D cycles to obtain the highest success rate.

Keyphrases

end stage renal disease
artificial intelligence
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
machine learning
patient reported outcomes
combination therapy
polycystic ovary syndrome
patient reported